No Data
Express News | Tibet Weixinkang Pharmaceutical: Subsidiary Yangpu Jingtai Calcium Gluconate Injection has passed the consistency evaluation for generic drugs.
Express News | Tibet Weixinkang Pharmaceutical: Children's multivitamin injection is renewed and included in the national medical insurance catalog.
Tibet Weixinkang Pharmaceutical (603676.SH): Subsidiary pharmaceuticals renewed in the national medical insurance catalog.
On November 29, Gelonghui reported that tibet weixinkang pharmaceutical (603676.SH) announced, according to the notice from the National Medical Insurance Administration and the Ministry of Human Resources and Social Security regarding the issuance of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Directory (2024)" (referred to as "National Medical Insurance Directory (2024)"), that the fully-owned subsidiary of tibet weixinkang pharmaceutical, inner mongolia baiyi pharmaceutical co., ltd., pediatric multi-vitamins injection (13) has been renewed and included in the "National Medical Insurance Directory (2024)" during the agreement period.
Tibet Weixinkang Pharmaceutical (603676) deep research report: domestic leader in parenteral nutrition, operational development welcomes a new cycle.
Tibet Weixinkang Pharmaceutical is a leading company in domestic parenteral nutrition medications. Tibet Weixinkang was established in 2006 and has been deeply engaged in the parenteral nutrition sector, possessing significant advantages in areas such as compound vitamins, intravenous trace elements, and intravenous electrolytes. The core product is an injectable multivitamin.
tibet weixinkang pharmaceutical (603676.SH): First-time repurchase of 0.1567 million shares of the company's stock
Gelonghui announced on November 25 that Tibet Weixinkang Pharmaceutical (603676.SH) has repurchased 156,700 shares of the company through centralized bidding for the first time on November 25, 2024, representing 0.0360% of the company's total share capital. The highest fill price was 9.9 yuan per share, the lowest fill price was 9.72 yuan per share, and the total transaction amount was 1,541,919 yuan (excluding commission and other trading fees).
Express News | Tibet Weixinkang Pharmaceutical: Subsidiary withdraws the registration application for compound amino acids (16) dipeptide (1) injection.
No Data
